We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000830:SZSELuxi Chemical Group Co., Ltd. Analysis

Data as of 2026-03-17 - not real-time

CN¥17.22

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading at 17.22 CNY, just above the computed support of 17.11 CNY and well below the 52‑week high of 21.8 CNY. Despite the price sitting under the 20‑day (18.82) and 50‑day (18.32) SMAs, the 200‑day SMA (14.27) remains comfortably lower, signaling a longer‑term bullish bias. Momentum indicators are mixed – RSI sits at 41.6, suggesting neutral pressure, while the MACD histogram is negative, hinting at short‑term bearishness. Volume is on an increasing trend, and the market sentiment index reads “Extreme Greed,” implying strong buyer enthusiasm. Volatility is elevated at nearly 70% over the past 30 days, yet the computed beta is almost zero, indicating low systematic market risk.
Fundamental backdrop: Revenue has contracted by roughly 5% year‑over‑year, and margins are modest (gross ~12%, operating ~11%). The company carries a debt‑to‑equity ratio of about 62%, with cash reserves covering only a fraction of total debt, which raises leverage concerns. Valuation metrics sit near the market median – forward P/E around 16.7, price‑to‑book 1.72, and price‑to‑sales 1.09 – while the dividend yield of 2.0% and a payout ratio under 50% suggest a reasonably sustainable payout. Analyst consensus is a “strong buy” with a target price near 18.5 CNY, implying upside of roughly 7‑8% from current levels.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above technical support
  • Mixed momentum signals (neutral RSI, bearish MACD)
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst upside potential of ~7‑8%
  • Attractive dividend yield with sustainable payout
  • Fair valuation relative to peers

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Elevated leverage and declining revenue trend
  • Cyclical nature of specialty chemicals sector
  • Stable dividend and moderate long‑term growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth-4.80%
Profit Margin4.91%
P/E Ratio22.4
ROE7.88%
ROA3.58%
Debt/Equity62.01
P/B Ratio1.7
Op. Cash FlowCN¥4.4B
Free Cash FlowCN¥100.0M

Technical Analysis

TrendBullish
RSI41.6
SupportCN¥17.11
ResistanceCN¥21.80
MA 20CN¥18.82
MA 50CN¥18.32
MA 200CN¥14.27
MACDBearish
VolumeIncreasing
Fear & Greed Index81.48

Valuation

Target PriceCN¥18.53
Upside/Downside7.63%
GradeFair
TypeBlend
Dividend Yield2.03%

Risk Assessment

Beta0.01
Volatility69.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.